Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting
Author(s) -
Fulan Xie,
Nian Yao,
Yao Qin,
Qianyu Zhang,
Huali Chen,
Mingqing Yuan,
Jie Tang,
Xiankun Li,
Wei Fan,
Qiang Zhang,
Yong Wu,
Hai Li,
Qin He
Publication year - 2012
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s23771
Subject(s) - liposome , biodistribution , in vivo , dispersity , biophysics , in vitro , drug delivery , chromatography , blood–brain barrier , ex vivo , biomedical engineering , chemistry , materials science , biochemistry , medicine , nanotechnology , biology , organic chemistry , microbiology and biotechnology , endocrinology , central nervous system
An intimidating challenge to transporting drugs into the brain parenchyma is the presence of the blood-brain barrier (BBB). Glucose is an essential nutritional substance for brain function sustenance, which cannot be synthesized by the brain. Its transport primarily depends on the glucose transporters on the brain capillary endothelial cells. In this paper, the brain-targeted properties of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers were compared and evaluated to establish an optimized drug-delivery system.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom